Final data from the phase 2a single-arm trial of SurVaxM for newly diagnosed glioblastoma

被引：0
|
作者：
Ciesielski, Michael J.
Ahluwalia, Manmeet Singh
Reardon, David A.
Abad, Ajay P.
Curry, William T.
Wong, Eric T.
Peereboom, David M.
Figel, Sheila A.
Hutson, Alan
Groman, Adrienne
Withers, Henry G.
Liu, Song
Belal, Ahmed
Qiu, Jing-Xin
Mogensen, Kathleen
Schilero, Cathy
Casucci, Danielle M.
Mechtler, Laszlo
Fenstermaker, Robert Alan
机构：
[1] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
[2] Taussig Canc Inst, Neurol Inst, Rose Ella Burkhardt Brain Tumor & Neuro Oncol Ctr, Cleveland, OH USA
[3] Cleveland Clin, Cleveland, OH USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
[6] Massachusetts Gen Hosp, Boston, MA USA
[7] Beth Israel Deaconess Med Ctr, Boston, MA USA
[8] MimiVax, Buffalo, NY USA
[9] Dent Neurol Inst, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2037
引用
收藏
页数：1
相关论文
共 50 条
  • [21] How to Improve the Efficacy of Venetoclax and Azacitidine(VA)for Newly Diagnosed Acute Myeloid Leukemia?a Prospective, Single-Center, Single-Arm, Phase 2 Trial for New Diagnosed AML
    Li, Xuekai
    Li, Mengyun
    Cui, Wei
    Chen, Xiaoqian
    Yu, Yan
    Chen, Juan
    Zhang, Xin
    Cui, Qingya
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2024, 144 : 4284 - 4284
  • [22] Orismilast for mild to severe hidradenitis suppurativa: Preliminary data from osiris, a phase 2a, open-label, single-center, single-arm clinical trial
    Frederiksen, Camilla Goetzsche
    Sedeh, Farnam Barati
    Taudorf, Elisabeth
    Saunte, Ditte M. L.
    Jemec, Gregor B. E.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 134 - 135
  • [23] Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial
    Xiaohui Suo
    Fang Zheng
    Dongmei Wang
    Liyun Zhao
    Jie Liu
    Ling Li
    Zhihua Zhang
    Congcong Zhang
    Yinling Li
    Sisi Yang
    Xuemei Zhao
    Rui Shi
    Yan Wu
    Zongjiu Jiao
    Jiaojie Song
    Ling Zhang
    Xinxiao Lu
    Linyu Yuan
    Sifeng Gao
    Jilei Zhang
    Xingli Zhao
    Guanchen Bai
    Kaiqi Liu
    Yingchang Mi
    Experimental Hematology & Oncology, 12
  • [24] A phase 0/2 trigger trial of niraparib in patients with newly diagnosed glioblastoma
    Mehta, Shwetal
    Sanai, Nader
    Margaryan, Tigran
    Molloy, Jennifer
    Zhang, Hualin
    Knight, William
    Harmon, Jocelyn
    Hong, Amy
    Wanebo, John
    Braun, Kelly
    Kennedy, William R.
    Garcia, Michael A.
    Barani, Igor J.
    Yoo, Wonsuk
    Tien, An-Chi
    Tovmasyan, Artak
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Phase 2 trial of bavituximab with chemoradiation and adjuvant temozolomide in newly diagnosed glioblastoma
    Ly, Ina
    Richardson, Leland
    Liu, Mofei
    Muzikansky, Alona
    Lou, Kevin
    Reardon, David A.
    Arrillaga-Romany, Isabel
    Forst, Deborah Anne
    Jordan, Justin T.
    Lee, Eudocia Quant
    Dietrich, Jorg
    Nayak, Lakshmi
    Wen, Patrick Y.
    Chukwueke, Ugonma Nnenna
    Giobbie-Hurder, Anita
    Choi, Bryan D.
    Batchelor, Tracy
    Kalpathy-Cramer, Jayashree
    Curry, William T.
    Gerstner, Elizabeth R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] Venetoclax combined with daunorubicin and cytarabine (2+6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial
    Suo, Xiaohui
    Zheng, Fang
    Wang, Dongmei
    Zhao, Liyun
    Liu, Jie
    Li, Ling
    Zhang, Zhihua
    Zhang, Congcong
    Li, Yinling
    Yang, Sisi
    Zhao, Xuemei
    Shi, Rui
    Wu, Yan
    Jiao, Zongjiu
    Song, Jiaojie
    Zhang, Ling
    Lu, Xinxiao
    Yuan, Linyu
    Gao, Sifeng
    Zhang, Jilei
    Zhao, Xingli
    Bai, Guanchen
    Liu, Kaiqi
    Mi, Yingchang
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [27] High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial
    Illerhaus, Gerald
    Kasenda, Benjamin
    Ihorst, Gabriele
    Egerer, Gerlinde
    Lamprecht, Monika
    Keller, Ulrich
    Wolf, Hans-Heinrich
    Hirt, Carsten
    Stilgenbauer, Stephan
    Binder, Mascha
    Hau, Peter
    Edinger, Matthias
    Frickhofen, Norbert
    Bentz, Martin
    Moehle, Robert
    Roeth, Alexander
    Pfreundschuh, Michael
    von Baumgarten, Louisa
    Deckert, Martina
    Hader, Claudia
    Fricker, Heidi
    Valk, Elke
    Schorb, Elisabeth
    Fritsch, Kristina
    Finke, Juergen
    Lancet Haematology, 2016, 3 (08): : E388 - E397
  • [28] Single-arm Phase II Survival Trial Design
    Benner, Axel
    BIOMETRICAL JOURNAL, 2022, 64 (07) : 1363 - 1363
  • [29] Phase II trial of copper depletion as angiosuppressive treatment in newly diagnosed Glioblastoma Multiforme: Final report.
    Brem, S
    Grossman, SA
    Carson, KA
    New, P
    Phuphanich, S
    Alavi, JB
    Mikkelsen, T
    Priet, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 114S - 114S
  • [30] A RANDOMIZED PHASE 2B STUDY OF SURVIVIN VACCINE SURVAXM PLUS ADJUVANT TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA (SURVIVE)
    Ahluwalia, M. S.
    Ciesielski, M.
    Abad, A.
    Reardon, D.
    Aiken, R.
    Barbaro, M.
    Sinicrope, K.
    Peereboom, D. M.
    Odia, Y.
    Brenner, A.
    Venur, V.
    Butowski, N.
    Belal, A.
    Qiu, J.
    Ozair, A.
    Khosla, A. A.
    Schilero, C.
    Figel, S.
    Casucci, D.
    Mechtler, L.
    Fenstermaker, R.
    NEURO-ONCOLOGY, 2023, 25
12345